YM 430

Drug Profile

YM 430

Alternative Names: YM 15430; YM 154301

Latest Information Update: 09 Feb 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yamanouchi
  • Class Antihypertensives
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Angina pectoris; Arrhythmias; Hypertension

Most Recent Events

  • 09 Feb 2000 No-Development-Reported for Angina pectoris in Japan (PO)
  • 09 Feb 2000 No-Development-Reported for Arrhythmias in Japan (Unknown route)
  • 09 Feb 2000 No-Development-Reported for Hypertension in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top